CCL26 and asthma: We report the effect of dupilumab on upper and lower airway outcomes in patients with CRSwNP and comorbid asthma from the SINUS-24/52 studies (NCT02912468/NCT02898454), categorized by baseline IgE, TARC, and eotaxin-3.